Position in PFE
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$4,679,152
-$1,044,337 QoQ
Shares Held
194,317
-4.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#622
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. PFE ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
This page
|
194,317 | $4,679,152 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,679,152 | 194,317 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $5,723,489 | 203,828 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $5,193,069 | 208,557 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $3,760,873 | 147,601 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $3,588,586 | 148,044 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $3,804,471 | 150,137 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $4,044,233 | 152,440 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $4,300,686 | 148,607 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $4,218,908 | 150,783 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $4,196,521 | 151,226 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,475,434 | 155,451 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $5,139,094 | 154,932 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $6,518,402 | 177,710 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $7,375,824 | 180,780 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $9,402,078 | 183,491 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $8,045,494 | 183,855 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $9,772,899 | 186,399 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $9,658,004 | 186,556 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $10,947,515 | 185,394 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $7,866,787 | 182,906 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $7,064,307 | 180,396 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $6,484,300 | 178,976 | Shares | Sole | 2021-04-06 | |
| 2020-12-31 | $6,450,142 | 175,228 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $6,449,027 | 175,723 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $5,835,124 | 178,444 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $5,883,319 | 180,249 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||